Israeli company Brainsway Ltd., which develops innovative devices for treatment of mental disorders using magnetic pulses, has announced that it has received US Food and Drug Administration (FDA) approval for its Deep TMS system. The system uses transcranial magnetic stimulation (TMS) for treating depression in patients who cannot be treated using standard methods.
Subscribe to NoCamels weekly newsletter and get our top stories
Related posts

Israeli AI Safety Tool Among TIME’S Best Inventions For 2024
October 31, 2024

TAU Team Discovers Mechanism To Eliminate Cancerous Tumors
October 30, 2024

Ashdod Port Investing In Startups As Part Of Innovation Strategy
October 29, 2024

BGU Develops Fast Fact Checking Via News Sources Not People
October 28, 2024
Facebook comments